Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 31: | Line 31: | ||
****[[Hepatocyte Growth Factor Receptor]] | ****[[Hepatocyte Growth Factor Receptor]] | ||
****[[Human Epidermal Growth Factor Receptor 2]] | ****[[Human Epidermal Growth Factor Receptor 2]] | ||
| + | ****Insulin-Like Growth Factor | ||
| + | *****[[Insulin-Like Growth Factor-1]] | ||
| + | *****[[Insulin-Like Growth Factor-1 Receptor]] | ||
****Vascular Growth Factor | ****Vascular Growth Factor | ||
*****[[Vascular Endothelial Growth Factor]] | *****[[Vascular Endothelial Growth Factor]] | ||
| Line 41: | Line 44: | ||
*****Mitogen-Activated Protein Kinase Kinase Kinase | *****Mitogen-Activated Protein Kinase Kinase Kinase | ||
******[[c-Raf]] | ******[[c-Raf]] | ||
| - | ****[[Phosphatidylinositol 3-Kinase] | + | ****[[Phosphatidylinositol 3-Kinase]]] |
| - | + | ||
***[[Farnesoid X Receptor]] | ***[[Farnesoid X Receptor]] | ||
***[[Heat Shock Protein 90]] | ***[[Heat Shock Protein 90]] | ||
Revision as of 09:15, 17 September 2010
The following is a list of major phamerceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
